2 ms·
in short, yes; and yes. the limitation is an understanding of the virus+host interaction at the level of molecular structure and function. when you have the a
by rolph 6y ago
in short, yes; and yes.
the limitation is an understanding of the virus+host interaction at the level of molecular structure and function.
when you have the amino acid sequence of a protien that triggers the immune system you can work backward and derive an mRNA that would be responsible for coding the protien.
there are multiple layers of complexity in getting from stage 1 to end product but this is a quick simple layout.
DNA virus has some extra tricks compared to RNA virus but the core concept is the same for both.
- bilal4hmed 6y agoWould such a technique help an immune compromised or suppressed person ?
- rolph 6y agoan immune compromised person may require larger repeated doses, or a different/concurrent strategy such as antibody infusion
- wittyreference 6y agoThe vaccine in this instance is all about delivering a target to the immune system's sentries. If those sentries are defective, or if the hitmen the sentries need to alert are defective, there's nothing this vaccine can do to change that. "Immune compromise" is generally used as a blanket term, but in many people there are specific immune deficiencies, which may or may not factor into the pathway being targeted here. For instance, natalizumab screws with immune cells' translocation across membranes, and shouldn't play a role in responding to a vaccine (I mean, if it wasn't off the market anyway). If it's a general immune dysfunction (cancer, diabetes), they will see some benefit, but it will be much reduced - specifically because both responding to the vaccine, and responding to the virus post-vaccination, require the activity of the immune system. What this means precisely will vary with the degree and nature of the immune dysfunction: some folks might see some antibody response, and benefit from repeat dosing. Others might fail to seroconvert altogether, in which case it is what it is.
- jbaudanza 6y agoI see, thanks for the reply! I was thinking that maybe because Covid is an RNA virus, there would be a shortcut to getting the mRNA sequence for creating the spike protein. The scientists could peek at the RNA in the actual virus, recognize the spike protein, and put that in the vaccine. Whereas with a DNA virus, it would require extra work. But from your answer, it sounds like that's not what they do? Or, maybe they could do that but it's not any easier than working backwards from the amino acid sequence. This stuff is all very interesting!
- rolph 6y agothe short cut is that DNA virus has a further layer of code utilization , the DNA must be read out and transcribed to mRNA, then translated to protien. there is an extra step in there, but you can still use a synthetic mRNA to create a protien specific to putative antigens decorating the surface of the DNA virus, or of the infected cell, or both if your rich and want to make sure. a DNA virus must be understood somewhat to find the reading frame for the protien you need, this is the case for RNA virus as well however RNA virus are limited in size due to the instability of RNA, this means less kruft to wade through until you find the FOO
- raphaelj 6y agoIs there a reason they don't create the protein in Vito and them inject it as a vaccine? I would imagine they could use in Vito cells to generate a lot of spike proteins. Are they using mRNA because it's easier to manufacture? Or is the protein too instable?
- rolph 6y agothe protien, and the mRNA would be instantly degraded outside the cell. the liposomal capsule holding the mRNA has been engineered to deliver the mRNA to the cell and fuse with it delivering the mRNA confoundingly the mRNA is fragile thus the ultracold dryice freezer required for holding. the protien is stable on its own, but will be destroyed by exocytic proteases unless shielded by insertion into a membrane